WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: AUGUST ISSUE PUBLISHED

    AUGUST 2026 Issue has been successfully launched on AUGUST 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR August 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

EPIDEMIOLOGICAL AND CLINICAL PROFILE OF AMOEBIASIS IN HOSPITALIZED CHILDREN IN MOSUL CITY

Reyad Ebraheem Hussien* MBChB CABP, Iman Idriss Yaseen MBChB FIBMS/FM, Zakariya Zuhair Al Hayali MBChB CABP

ABSTRACT

Background: Amoebiasis, caused by the protozoan parasite Entamoeba histolytica, presents a major public health challenge in developing countries characterized by substandard water sanitation infrastructure. Objectives: This prospective case series aimed to investigate the clinical, macroscopic, biological, and socio-demographic parameters of pediatric amoebiasis cases admitted to Al-Khansaa Maternity and Pediatric Teaching Hospital in Mosul. Methods: From March 1 to June 30, 2014, 96 children under 10 years of age exhibiting diarrheal symptoms and microscopically confirmed E. histolytica trophozoites in fresh stool samples were monitored sequentially. Results: The study cohort comprised 59 males (61.14%) and 37 females (38.54%), establishing a male-to-female ratio of 1.6:1. Infants aged 1–12 months were highly vulnerable, making up 46.87% (n=45) of cases, with a peak frequency among those aged 6–12 months (32.29%, n=31). Urban residents constituted 63.54% (n=61). Paradoxically, 86.45% (n=83) of infected families utilized municipal tap water. Clinical evaluation showed that 67.7% (n=65) presented with fever (>=38°C), 75% (n=72) with abdominal pain, and 55.2% (n=53) with macroscopically distinct blood and mucus (clinical dysentery). Mild-to-moderate dehydration was identified in 61.4% (n=59), while 3.1% (n=3) suffered severe dehydration. Concomitant stool cultures for dysenteric samples revealed secondary bacterial infestations with Escherichia coli in 22.6% (n=12) and Salmonella in 3.7% (n=2); no Shigella growth was observed. Conclusions: Infant cohorts aged 6–12 months and formula/mixed-fed children exhibit heightened vulnerability. Traditional municipal chlorination proves insufficient against amebic cysts, necessitating mandatory water boiling and targeted dual tissue/luminal therapeutic regimens.

[Full Text Article] [Download Certificate]